Press Release Archives - HealthCare Royalty

September 6, 2022

Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Granted Marketing Authorization by European Commission for Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome

August 8, 2022

Clearside Biomedical Enters into Non-Dilutive Financing Agreement with HealthCare Royalty Partners for up to $65 Million

September 30, 2021

Spero Therapeutics Enters Into a Non-Dilutive Revenue Interest Financing Agreement With HealthCare Royalty Partners^® for Up to $125 Million

January 6, 2021

HCR Expands Team and Announces Promotions

December 22, 2020

REGENXBIO Announces Agreement to Monetize Portion of Zolgensma^® Royalties for $200 Million

December 22, 2020

Nektar Therapeutics Announces Agreement with Healthcare Royalty to Sell ADYNOVATE^® and MOVANTIK^® Royalties for $150 Million

August 31, 2020

Chiasma Announces U.S. Commercial Launch and Availability of MYCAPSSA®, the First and Only Oral Somatostatin Analog for Patients with Acromegaly

July 7, 2020

HCR Partners Announces Two New Appointments to Senior Advisor Board

April 8, 2020

Chiasma Enters Into Revenue Interest Financing Agreement for up to $75 Million with Healthcare Royalty Partners

January 9, 2020

HealthCare Royalty Partners Raises $1.8 Billion